Athersys to Host Third Quarter 2013 Financial Results Call

Athersys to Host Third Quarter 2013 Financial Results Call
The Company is developing its MultiStem(R) cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas. The Company … Read more on Wall Street Journal

A Better Pill to Swallow
Like Alzheimer's patients, depression sufferers show damage there. A growing body of evidence suggests that … Unlike fetal stem cells, which hold medical promise because scientists can transform them into any cell in the body, neural stem cells only … Read more on BethesdaMagazine.com